Skip to main content
Equibles
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Short Interest

Track IKT — free

Use IKT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IKT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.53 -0.10 (-6.13%) At close · Nov 12 Q2 2024 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$214.61M
Shares
140.27M
Volume · Nov 12 728.31K Avg daily vol (3M) 566.38K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

IKT Latest Reported Short Interest

FINRA reported 19,428,875 IKT shares sold short as of the October 30, 2026 settlement date, a decrease of 197,309 shares. Days to cover was 28.59 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

IKT Short Interest Forecast

Equibles' model estimates 19,804,027 shares sold short for the November 13, 2026 settlement, +1.9% versus the latest reported position, with a likely range of 18,452,810 to 21,293,606 shares. This model prediction uses FINRA data through November 12, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 12 High confidence 67% chance it rises
19,804,027 +1.9% vs reported
Likely range 18,452,810 to 21,293,606 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
63/100
Short interest 13.9% of shares — P94 Days to cover 28.6 — P97 Price vs VWAP -22.8% — P22 Short-volume trend -8.8% — P22 Short interest change -1.0% — P50 Worst FTD 0.00% of shares — P36

Positioning score 62.8 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-13 06:27 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-11-30 Scheduled
    FINRA publishes Dec 9
    		 — — — —
    2026-11-13 Scheduled
    FINRA publishes Nov 24
    		 — — — —
    2026-10-30 19,428,875 19,626,184 -197,309 28.59
    2026-10-15 19,626,184 19,430,194 +195,990 31.05
    2026-09-30 19,430,194 18,518,754 +911,440 27.01
    2026-09-15 18,518,754 19,489,554 -970,800 47.49
    2026-08-31 19,489,554 19,666,839 -177,285 47.39
    2026-08-14 19,666,839 19,135,668 +531,171 35.53
    2026-07-31 19,135,668 18,261,416 +874,252 21.49
    2026-07-15 18,261,416 19,421,754 -1,160,338 16.94
    2026-06-30 19,421,754 18,894,930 +526,824 17.38
    2026-06-15 18,894,930 18,509,827 +385,103 34.36
    2026-05-29 18,509,827 17,690,807 +819,020 24.57
    2026-05-15 17,690,807 17,979,022 -288,215 26.52
    2026-04-30 17,979,022 17,790,305 +188,717 17.10
    2026-04-15 17,790,305 17,261,276 +529,029 19.25
    2026-03-31 17,261,276 16,037,365 +1,223,911 8.42
    2026-03-13 16,037,365 16,041,114 -3,749 11.91
    2026-02-27 16,041,114 10,541,776 +5,499,338 4.61
    2026-02-13 10,541,776 8,839,652 +1,702,124 12.48
    2026-01-30 8,839,652 7,601,911 +1,237,741 17.85
    2026-01-15 7,601,911 6,753,894 +848,017 14.69
    2025-12-31 6,753,894 5,345,574 +1,408,320 8.50
    2025-12-15 5,345,574 4,142,443 +1,203,131 13.78
    2025-11-28 4,142,443 3,085,555 +1,056,888 7.68
    2025-11-14 3,085,555 3,027,973 +57,582 23.59

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 48 filings 45 filers Visit website Investor relations